Created by Frank Papay, MD, Chairman of Dermatology and Plastic Surgery, Cleveland Clinic, the technology is a next generation implant device for the treatment of obstructive sleep apnea (OSA). The neurostimulator electrode is implanted locally and activated externally. The device electrodes stimulate a portion of the hypoglossal nerve that contracts the anterior lingual musculature whose actions relieves the apnea event, which results in a more open oropharyngeal airway, which increases airflow and prevents obstruction during sleep. This next generation technology works proactively, unlike existing technology which reacts after the apnea event. The primary goal of this device is to increase oropharyngeal airflow, thereby preventing obstructive sleep apnea.